Lab Med Online.  2017 Jan;7(1):49-51. 10.3343/lmo.2017.7.1.49.

Plasma Cell Myeloma in a Patient with Chronic Myelogenous Leukemia

• Lee JH
• Kim YK

• KMID: 2363008
• DOI: http://doi.org/10.3343/lmo.2017.7.1.49

Abstract

No abstract available.

MeSH Terms

Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Multiple Myeloma*
Plasma Cells*
Plasma*

Reference

1. Ahn S, Park JS, Han JH, Cho SR. A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient. Ann Lab Med. 2015; 35:370–372.

2. Maerki J, Katava G, Siegel D, Silberberg J, Bhattacharyya PK. Unusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder. Case Rep Hematol. 2014; 2014:738428.

3. Pilot PR, Sablinska K, Owen S, Hatfield A. Epidemiological analysis of second primary malignancies in more than 9500 patients treated with imatinib. Leukemia. 2006; 20:148. author reply 149.

4. Verma D, Kantarjian H, Strom SS, Rios MB, Jabbour E, Quintas-Cardama A, et al. Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies. Blood. 2011; 118:4353–4358.

5. Guru Murthy GS, Sawyer J, Alapat D, Samant R, Barlogie B. Strange bedfellows: mitotically active chronic myeloid leukemia in molecular complete remission, detected in focal lesion of myeloma. Clin Lymphoma Myeloma Leuk. 2014; 14:e127–e129.

6. Ide M, Kuwahara N, Matsuishi E, Kimura S, Gondo H. Uncommon case of chronic myeloid leukemia with multiple myeloma. Int J Hematol. 2010; 91:699–704.

7. Galanopoulos A, Papadhimitriou SI, Kritikou-Griva E, Georgiakaki M, Anagnostopoulos NI. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia. Ann Hematol. 2009; 88:281–282.

8. Michael M, Antoniades M, Lemesiou E, Papaminas N, Melanthiou F. Development of multiple myeloma in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate for 65 months. Oncologist. 2009; 14:1198–1200.

9. Garipidou V, Vakalopoulou S, Tziomalos K. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate. Oncologist. 2005; 10:457–458.

10. Derghazarian C, Whittemore NB. Multiple myeloma superimposed on chronic myelocytic leukemia. Can Med Assoc J. 1974; 110:1047–1050.